Regulators are due to decide Thursday whether to uphold, revise or scrap longstanding restrictions on the abortion drug mifepristone
Related posts:
FDA fights for independence in Trump administration’s final days
Biden dresses down his Covid team over plans to speed vaccinations
States struggle for control of chaotic vaccine rollout
Trump misses 20 million Covid shot target
Johnson & Johnson vaccine hits production snags
White House weighs sending states’ unused vaccine doses abroad — before they expire
Sweeney, Coughlin introduce new bill to end health emergency, limit Murphy’s powers
Black Americans lag in Biden’s vaccine equity push
Fauci: ‘I don’t think we’re going to see lockdowns’
FDA targets early September for approving Pfizer’s Covid-19 vaccine
No ‘clear’ messaging about pandemic from Biden and Trump administrations, Maryland’s governor says
Ire over pharmacy middlemen fuels lobbying blitz
